EcoDrugPlus

Sucrase-Isomaltase

Ensembl ID : ENSG00000090402
Gene: SI
Gene Synonyms:
2 APIs:
7 Enzyme and pathways 8 Cross references
201 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Synuclein Alpha

Ensembl ID : ENSG00000145335
Gene: SNCA
Gene Synonyms: NACP,PARK1,PARK4,PD1
2 APIs:
2 Enzyme and pathways 8 Cross references
189 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Tachykinin Receptor 1

Ensembl ID : ENSG00000115353
Gene: TACR1
Gene Synonyms: NK1R,NKIR,SPR,TAC1R
15 APIs:
12 Enzyme and pathways 7 Cross references
271 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Tachykinin Receptor 2

Ensembl ID : ENSG00000075073
Gene: TACR2
Gene Synonyms: NK2R,NKNAR,SKR,TAC2R
2 APIs:
8 Enzyme and pathways 7 Cross references
200 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Tachykinin Receptor 3

Ensembl ID : ENSG00000169836
Gene: TACR3
Gene Synonyms: NK3R,NKR,TAC3R
3 APIs:
8 Enzyme and pathways 8 Cross references
258 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Telomerase Reverse Transcriptase

Ensembl ID : ENSG00000164362
Gene: TERT
Gene Synonyms: EST2,HEST2,TCS1,TP2,TRT
2 APIs:
9 Enzyme and pathways 9 Cross references
188 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Thromboxane A Synthase 1

Ensembl ID : ENSG00000059377
Gene: TBXAS1
Gene Synonyms: CYP5,CYP5A1,THAS,TS,TXAS,TXS
3 APIs:
13 Enzyme and pathways 9 Cross references
219 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Thromboxane A2 Receptor

Ensembl ID : ENSG00000006638
Gene: TBXA2R
Gene Synonyms:
4 APIs:
13 Enzyme and pathways 9 Cross references
194 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Thymidine Phosphorylase

Ensembl ID : ENSG00000025708
Gene: TYMP
Gene Synonyms: ECGF1,MNGIE
1 APIs:
6 Enzyme and pathways 9 Cross references
173 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Thymidylate Synthetase

Ensembl ID : ENSG00000176890
Gene: TYMS
Gene Synonyms: HST422,TMS,TS,TSASE
9 APIs:
8 Enzyme and pathways 9 Cross references
222 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Thyroid Hormone Receptor Beta

Ensembl ID : ENSG00000151090
Gene: THRB
Gene Synonyms: C-ERBA-2,C-ERBA-BETA,ERBA-BETA,ERBA2,GRTH,NR1A2,PRTH,THR1,THRB1,THRB2,THRBETA,THRBETA1,THRBETA2,TRB,TRBETA,TRBETA1
3 APIs:
9 Enzyme and pathways 8 Cross references
393 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSG00000174417
Gene: TRHR
Gene Synonyms:
1 APIs:
7 Enzyme and pathways 8 Cross references
269 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).